Announcements Trials
Browse Landscape

Phase

Phase NA 24Phase 2 8Phase 1 4Phase 3 2Phase 4 1Phase 1/2 1

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 4Genitourinary 4Head & Neck 3Other hematologic neoplasm 2Gynecologic 2Gastrointestinal 2Tumor-Agnostic 1Thoracic 1Lymphoid 1Classical hematology 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 3Urinary Bladder Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma in Situ 1

Interventions

pembrolizumab 93Nivolumab 61Docetaxel 55Cyclophosphamide 49enzalutamide 44Magnetic Resonance Spectroscopy 33Ipilimumab 33Gemcitabine 32Abiraterone Acetate 30Prednisone 29fludarabine 28Everolimus 27Paclitaxel 25Cisplatin 24Radiotherapy 23Carboplatin 23Sunitinib 22cabozantinib 21atezolizumab 20Radiosurgery 20Specimen Handling 19Sorafenib 18Bevacizumab 18pazopanib 17bicalutamide 17abiraterone 17Biopsy 15temsirolimus 14darolutamide 14apalutamide 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Surveys and Questionnaires × Genitourinary × Clear all
NCT07145177 2026-06-01

177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer

University of California, San Francisco

Phase 1 Recruiting
30 enrolled
Genitourinary

Prostatic Neoplasms

NCT02048150 2026-05-29

Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer

City of Hope Medical Center

Phase 1 Completed
7 enrolled
Genitourinary

Prostatic Neoplasms

NCT02572284 2023-01-19

Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
7 enrolled
Genitourinary

Prostatic Neoplasms

NCT03106610 2018-05-24

Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy

M.D. Anderson Cancer Center

Phase 1 Terminated
1 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡